相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Two novel GALNT3 mutations in familial tumoral calcinosis
Holly J. Garringer et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Shoji Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations
Shoji Ichikawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
Regina Goetz et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Hyperostosis-hyperphosphatemia syndrome:: A congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23
Yaacov Frishberg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
The role of mutant UDP-N-acetyl-α-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis
Holly J. Garringer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis - Secretion of fibroblast growth factor 23 requires O-glycosylation
Kentaro Kato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family
MF Campagnoli et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Regulation of fibroblast growth factor-23 signaling by Klotho
H Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred
Polina Specktor et al.
JOURNAL OF HUMAN GENETICS (2006)
A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification
I Chefetz et al.
HUMAN GENETICS (2005)
A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis
K Araya et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis
T Larsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis:: Evidence that the disorder is autosomal recessive
S Ichikawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
A Benet-Pagès et al.
HUMAN MOLECULAR GENETICS (2005)
Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed
T Larsson et al.
ENDOCRINOLOGY (2005)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis
O Topaz et al.
NATURE GENETICS (2004)
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
KB Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
KE White et al.
KIDNEY INTERNATIONAL (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
Introduction: aging research comes of age
M Kuro-o
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
分享论文
